Hexarelin Research & Studies
We track 20 published, PubMed-indexed studies for Hexarelin, spanning 1994 to 2026. The research below includes 9 research articles, 4 reviews, 7 clinical trials.
These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
9
Research Articles
4
Reviews
7
Clinical Trials
Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection.
Research ArticleChow KBS|Indian J Pharmacol|2026
Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway.
Research ArticleGuan C, Li C, et al.|Eur J Med Res|2023
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein.
Research ArticleMeanti R, Licata M, et al.|Int J Mol Sci|2023
Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.
Research ArticleJiang B, Wang M, et al.|Microvasc Res|2022
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury.
Research ArticleZambelli V, Rizzi L, et al.|Drug Target Insights|2021
Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity.
Research ArticleMeanti R, Rizzi L, et al.|Pharmaceuticals (Basel)|2021
Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats.
Research ArticleBaser T, Ozdemir E, et al.|Can J Physiol Pharmacol|2021
Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion.
Research ArticleMcDonald H, Peart J, et al.|Biomed Pharmacother|2020
Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy via the regulation of autophagy.
Research ArticleAgbo E, Li MX, et al.|Pharmazie|2019
The Safety and Efficacy of Growth Hormone Secretagogues.
ReviewSigalos JT, Pastuszak AW|Sex Med Rev|2018
Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.
ReviewMosa RM, Zhang Z, et al.|Endocrine|2015
The cardiovascular action of hexarelin.
ReviewMao Y, Tokudome T, Kishimoto I|J Geriatr Cardiol|2014
We are ageing.
ReviewKolovou GD, Kolovou V, Mavrogeni S|Biomed Res Int|2014
Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
Clinical TrialBroglio F, Guarracino F, et al.|Eur J Pharmacol|2002
Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome.
Clinical TrialCoiro V, Volpi R, et al.|J Intern Med|2000
Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Clinical TrialMassoud AF, Hindmarsh PC, Brook CG|Clin Endocrinol (Oxf)|1997
Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients.
Clinical TrialCiccarelli E, Grottoli S, et al.|Clin Endocrinol (Oxf)|1996
The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
Clinical TrialMassoud AF, Hindmarsh PC, et al.|Clin Endocrinol (Oxf)|1996
Hexarelin induced growth hormone release is influenced by exogenous growth hormone.
Clinical TrialMassoud AF, Hindmarsh PC, Brook CG|Clin Endocrinol (Oxf)|1995
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Clinical TrialArvat E, Gianotti L, et al.|J Clin Endocrinol Metab|1994